Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP428983.RADVdc01nTYZW2r-szlrweol08BILGuI6eYYiWtKLloM0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP428983.RADVdc01nTYZW2r-szlrweol08BILGuI6eYYiWtKLloM0130_assertion type Assertion NP428983.RADVdc01nTYZW2r-szlrweol08BILGuI6eYYiWtKLloM0130_head.
- NP428983.RADVdc01nTYZW2r-szlrweol08BILGuI6eYYiWtKLloM0130_assertion description "[Ten years after diagnosis, 35% of CD and 51% of CRD had a bull's eye maculopathy; 70% of CRD showed absolute peripheral visual field defects and 37% of CD developed rod involvement on ERG.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP428983.RADVdc01nTYZW2r-szlrweol08BILGuI6eYYiWtKLloM0130_provenance.
- NP428983.RADVdc01nTYZW2r-szlrweol08BILGuI6eYYiWtKLloM0130_assertion evidence source_evidence_literature NP428983.RADVdc01nTYZW2r-szlrweol08BILGuI6eYYiWtKLloM0130_provenance.
- NP428983.RADVdc01nTYZW2r-szlrweol08BILGuI6eYYiWtKLloM0130_assertion SIO_000772 22264887 NP428983.RADVdc01nTYZW2r-szlrweol08BILGuI6eYYiWtKLloM0130_provenance.
- NP428983.RADVdc01nTYZW2r-szlrweol08BILGuI6eYYiWtKLloM0130_assertion wasDerivedFrom befree-20140225 NP428983.RADVdc01nTYZW2r-szlrweol08BILGuI6eYYiWtKLloM0130_provenance.
- NP428983.RADVdc01nTYZW2r-szlrweol08BILGuI6eYYiWtKLloM0130_assertion wasGeneratedBy ECO_0000203 NP428983.RADVdc01nTYZW2r-szlrweol08BILGuI6eYYiWtKLloM0130_provenance.